Bone and Joint Infection

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MaaT Pharma
MaaT PharmaFrance - Lyon
1 program
Biological samples collection of blood and fecesN/A1 trial
Active Trials
NCT03011502CompletedEst. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MaaT PharmaBiological samples collection of blood and feces

Clinical Trials (1)

NCT03011502MaaT PharmaBiological samples collection of blood and feces

InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS

Start: Dec 2016Est. completion: Mar 2018
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space